Lord, Abbett & Co. LLC Veracyte, Inc. Transaction History
Lord, Abbett & Co. LLC
- $31.4 Billion
- Q3 2024
A detailed history of Lord, Abbett & Co. LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 279,032 shares of VCYT stock, worth $12.6 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
279,032
Previous 279,032
-0.0%
Holding current value
$12.6 Million
Previous $9.5 Million
-0.0%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding VCYT
# of Institutions
316Shares Held
81.8MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$351 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$349 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$226 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$222 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$191 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.23B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...